在黑色素瘤中,Mi-2β通过激活EZH2甲基化来促进免疫逃避
Cang Li1,2, Zhengyu Wang3, Licheng Yao4
1Skin Disease Research Institute, The 2nd Hospital and School of Medicine, Zhejiang University, Hangzhou, 310058, China.
Nature communications
|March 9, 2024
概括
研究人员将Mi-2β确定为克服抗癌免疫疗法的目标. 抑制Mi-2β可以使抗性黑色素瘤瘤对免疫检查点抑制剂重新敏感,改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 免疫检查点抑制剂 (ICI) 在癌症治疗中表现有前途,但许多患者没有反应.
- 开发将抗性瘤转化为免疫疗法敏感的策略对于改善患者的治疗结果至关重要.
研究的目的:
- 确定调节适应性抗瘤免疫反应的关键黑色素瘤内在因素.
- 探索Mi-2β作为克服抗癌免疫疗法的治疗标.
主要方法:
- 利用基因工程小鼠黑色素瘤模型.
- 进行ATAC-seq分析以评估基因可访问性.
- 研究了Mi-2β和EZH2.2.之间的相互作用.
- 开发并测试了一种针对Mi-2β的抑制剂 (Z36-MP5).
主要成果:
- 在体内免疫治疗中,Mi-2β的损失挽救了免疫反应.
- 米-2β控制了干扰素马刺激基因 (ISG) 的可访问性.
- 米-2β促进EZH2甲基化,抑制ISG转录.
- 在耐性黑色素瘤模型中,Z36-MP5重新激活了ISG转录,并诱导了ICI反应.
结论:
- 米-2β是黑色素瘤对免疫治疗反应的关键调节者.
- 用Z36-MP5准Mi-2β提供了一个潜在的治疗策略,可以将免疫疗法耐药的黑色素瘤转化为敏感的黑色素瘤.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Epigenetic Regulation
31.1K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.1K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K


